Naxing Xu Raymond, Fan Leimin, Kim Grace E, El-Shourbagy Tawakol A
Abbott Laboratories, Department of Drug Analysis, 100 Abbott Park Road, Abbott Park, IL 60064, USA.
J Pharm Biomed Anal. 2006 Feb 24;40(3):728-36. doi: 10.1016/j.jpba.2005.10.001. Epub 2005 Nov 14.
An automated procedure using monolithic-phase based on-line extraction is described for pharmaceutical component analysis in plasma by LC-MS/MS. In this approach, a short monolithic C(18) 4.6 mm x 10 mm cartridge is used for high flow extraction at 4 mL/min. Plasma samples were subjected to protein precipitation first with acetonitrile, and the supernatant was diluted and loaded onto a monolithic cartridge. Sample elution was accomplished with narrow-bore LC-MS/MS system. A method for determination of Amprenavir (APV) and Atazanavir (AZV) in human plasma was developed with this approach. After 0.1 mL of plasma was transferred into each well of a 96-well plate by a liquid handler, the rest of sample preparation time typically only takes about 20 min. A Phenomenex Luna C18(2) 2.0 mm x 150 mm analytical column was used for the separation at a flow rate of 0.3 mL/min. The run time for each sample was 4 min. The standard curve range was 2.77-1520 ng/mL for Atazanavir, and 4.50-2560 ng/mL for Amprenavir. The accuracy (%bias) at the lower limit of quantitation (LLOQ) for Atazanavir was 2.7% and the precision (%CV) at the LLOQ was 7.9%, while the accuracy at LLOQ for Amprenavir was -1.3% and the precision at LLOQ was 7.8%. The inter-day %bias and %CV of the quality control samples of Atazanavir were < or = 4.5% and < or = 6.5%, respectively. The inter-day %bias and %CV of the quality control samples of Amprenavir were < or = 1.1% and < or = 7.2%, respectively. Coefficients of determination, a measure of linearity, ranged from 0.993 to 0.999. Very low carry-over (0.006%) even after high standard sample was demonstrated in the monolithic-phase based method. Other characteristics of such method include high recovery and good tolerance to matrix effect, which was demonstrated by 12 lots of plasma. The back pressure of the monolithic extraction cartridge remained the same after 450 samples injected. The performance of the monolithic-phased on-line extraction method was compared with that done by an automated 96-well liquid-liquid extraction procedure, which was carried out using hexane:ethyl acetate as the extraction solvent. The results showed that similar precision and accuracy were achieved by both methods.
本文描述了一种基于整体柱在线萃取的自动化方法,用于通过液相色谱-串联质谱法(LC-MS/MS)分析血浆中的药物成分。在该方法中,使用一根短的整体式C(18) 4.6 mm×10 mm柱管在4 mL/min的流速下进行高流量萃取。血浆样品首先用乙腈进行蛋白沉淀,上清液经稀释后加载到整体柱管上。样品洗脱通过窄径LC-MS/MS系统完成。利用该方法建立了一种测定人血浆中安普那韦(APV)和阿扎那韦(AZV)的方法。用液体处理器将0.1 mL血浆转移到96孔板的每个孔中后,其余的样品制备时间通常仅需约20分钟。使用Phenomenex Luna C18(2) 2.0 mm×150 mm分析柱,以0.3 mL/min的流速进行分离。每个样品的运行时间为4分钟。阿扎那韦的标准曲线范围为2.77 - 1520 ng/mL,安普那韦的标准曲线范围为4.50 - 2560 ng/mL。阿扎那韦在定量下限(LLOQ)处的准确度(%偏差)为2.7%,LLOQ处的精密度(%CV)为7.9%,而安普那韦在LLOQ处的准确度为 -1.3%,LLOQ处的精密度为7.8%。阿扎那韦质量控制样品的日间%偏差和%CV分别≤4.5%和≤6.5%。安普那韦质量控制样品的日间%偏差和%CV分别≤1.1%和≤7.2%。测定系数(衡量线性的指标)范围为0.993至0.999。基于整体柱的方法即使在进样高浓度标准样品后也显示出极低的残留(0.006%)。该方法的其他特性包括高回收率和对基质效应的良好耐受性,12批血浆的检测结果证明了这一点。在进样450个样品后,整体萃取柱管的背压保持不变。将整体柱在线萃取方法的性能与使用己烷:乙酸乙酯作为萃取溶剂的自动化96孔液液萃取方法进行了比较。结果表明,两种方法获得了相似的精密度和准确度。